BRAIN Biotech AG (BNN) - Total Liabilities

Latest as of September 2025: €64.50 Million EUR ≈ $75.40 Million USD

Based on the latest financial reports, BRAIN Biotech AG (BNN) has total liabilities worth €64.50 Million EUR (≈ $75.40 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BNN operating cash flow to assess how effectively this company generates cash.

BRAIN Biotech AG - Total Liabilities Trend (2012–2025)

This chart illustrates how BRAIN Biotech AG's total liabilities have evolved over time, based on quarterly financial data. Check BRAIN Biotech AG (BNN) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

BRAIN Biotech AG Competitors by Total Liabilities

The table below lists competitors of BRAIN Biotech AG ranked by their total liabilities.

Company	Country	Total Liabilities
Optipharm.CO.LTD KQ:153710	Korea	₩16.61 Billion
Ipopema Securities SA WAR:IPE	Poland	zł700.09 Million
Futuretech II Acquisition Corp NASDAQ:FTII	USA	$10.38 Million
Shree Rama Newsprint Limited NSE:RAMANEWS	India	Rs5.38 Billion
Yesil Yapi Endustrisi AS IS:YYAPI	Turkey	TL1.63 Billion
Cineverse Corp. NASDAQ:CNVS	USA	$30.83 Million
OPPSTAR KLSE:0275	Malaysia	RM7.21 Million
Silvano Fashion Group AS WAR:SFG	Poland	zł12.73 Million

Liability Composition Analysis (2012–2025)

This chart breaks down BRAIN Biotech AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BNN market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.35	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	35.03	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.97	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BRAIN Biotech AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BRAIN Biotech AG (2012–2025)

The table below shows the annual total liabilities of BRAIN Biotech AG from 2012 to 2025.

Year	Total Liabilities	Change
2025-09-30	€64.50 Million ≈ $75.40 Million	-13.83%
2024-09-30	€74.85 Million ≈ $87.51 Million	+56.19%
2023-09-30	€47.92 Million ≈ $56.03 Million	+9.55%
2022-09-30	€43.74 Million ≈ $51.14 Million	+21.82%
2021-09-30	€35.91 Million ≈ $41.98 Million	-21.95%
2020-09-30	€46.01 Million ≈ $53.79 Million	-6.17%
2019-09-30	€49.03 Million ≈ $57.32 Million	+11.88%
2018-09-30	€43.83 Million ≈ $51.24 Million	+107.29%
2017-09-30	€21.14 Million ≈ $24.72 Million	+2.70%
2016-09-30	€20.59 Million ≈ $24.07 Million	-16.49%
2015-09-30	€24.65 Million ≈ $28.82 Million	+119.64%
2014-09-30	€11.22 Million ≈ $13.12 Million	+49.55%
2013-09-30	€7.51 Million ≈ $8.77 Million	-1.08%
2012-09-30	€7.59 Million ≈ $8.87 Million	--

About BRAIN Biotech AG

XETRA:BNN Germany Specialty Chemicals

Market Cap

$70.50 Million

€60.30 Million EUR

Market Cap Rank

#21764 Global

#1934 in Germany

Share Price

€2.76

Change (1 day)

+0.00%

52-Week Range

€1.85 - €3.66

All Time High

€27.50